Literature DB >> 7937104

Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding.

P A Norton1.   

Abstract

IVS1, an intron derived from the rat fibronectin gene, is spliced inefficiently in vitro, involving the use of three alternative branch sites. Mutation of one branch point site, BP3, so as to increase complementarity to U2 snRNA resulted in exclusive use of that site and improved splicing efficiency, indicating that the wild type BP3 site is one determinant of poor IVS1 splicing. Deletions within the polypyrimidine tract had a variable effect on splicing efficiency and altered the pattern of branch site usage. Selection of each branch site was influenced negatively by purine substitutions ca. 20 nucleotides downstream. It is proposed that all three IVS1 branch sites are pyrimidine tract-dependent. Pyrimidine tract deletions also influenced the crosslinking of PTB (the polypyrimidine tract-binding protein), hnRNP C, and splicing factor U2AF65. All three proteins bound preferentially to distinct regions within the polypyrimidine tract and thus are candidates for mediating pyrimidine tract-dependent branch site selection. The findings indicate the complexity of the IVS1 polypyrimidine tract and suggest a crucial role for this region in modulating branch site selection and IVS1 splicing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937104      PMCID: PMC308380          DOI: 10.1093/nar/22.19.3854

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  45 in total

1.  Splicing of SV40 early pre-mRNA to large T and small t mRNAs utilizes different patterns of lariat branch sites.

Authors:  J C Noble; Z Q Pan; C Prives; J L Manley
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

2.  U2 as well as U1 small nuclear ribonucleoproteins are involved in premessenger RNA splicing.

Authors:  D L Black; B Chabot; J A Steitz
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

3.  Splicing of messenger RNA precursors.

Authors:  P A Sharp
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

Review 4.  Pre-mRNA splicing.

Authors:  M R Green
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

5.  A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly.

Authors:  B Ruskin; P D Zamore; M R Green
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

6.  In vitro splicing of adenovirus E1A transcripts: characterization of novel reactions and of multiple branch points abnormally far from the 3' splice site.

Authors:  R Gattoni; P Schmitt; J Stevenin
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

7.  Unusual branch point selection in processing of human growth hormone pre-mRNA.

Authors:  K Hartmuth; A Barta
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA.

Authors:  R Parker; P G Siliciano; C Guthrie
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

9.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates.

Authors:  J F Milligan; D R Groebe; G W Witherell; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

Review 10.  Alternative pre-mRNA splicing: factors involved in splice site selection.

Authors:  P A Norton
Journal:  J Cell Sci       Date:  1994-01       Impact factor: 5.285

View more
  39 in total

1.  Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion.

Authors:  J Côté; S Dupuis; J Y Wu
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

2.  Combinatorial control of a neuron-specific exon.

Authors:  E F Modafferi; D L Black
Journal:  RNA       Date:  1999-05       Impact factor: 4.942

Review 3.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 4.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  Co-transcriptional splicing of constitutive and alternative exons.

Authors:  Amy Pandya-Jones; Douglas L Black
Journal:  RNA       Date:  2009-08-05       Impact factor: 4.942

6.  Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats.

Authors:  L P Lim; P A Sharp
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Functional crosstalk between exon enhancers, polypyrimidine tracts and branchpoint sequences.

Authors:  M Buvoli; S A Mayer; J G Patton
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

8.  Characterization of human GTPBP3, a GTP-binding protein involved in mitochondrial tRNA modification.

Authors:  Magda Villarroya; Silvia Prado; Juan M Esteve; Miguel A Soriano; Carmen Aguado; David Pérez-Martínez; José I Martínez-Ferrandis; Lucía Yim; Victor M Victor; Elvira Cebolla; Asunción Montaner; Erwin Knecht; M-Eugenia Armengod
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

9.  A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG.

Authors:  Yui Jin; Hitoshi Suzuki; Shingo Maegawa; Hitoshi Endo; Sumio Sugano; Katsuyuki Hashimoto; Kunio Yasuda; Kunio Inoue
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

10.  The use of antibodies to the polypyrimidine tract binding protein (PTB) to analyze the protein components that assemble on alternatively spliced pre-mRNAs that use distant branch points.

Authors:  J S Grossman; M I Meyer; Y C Wang; G J Mulligan; R Kobayashi; D M Helfman
Journal:  RNA       Date:  1998-06       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.